|
???tair.name??? >
???browser.page.title.author???
|
"liu chen hua"???jsp.browse.items-by-author.description???
Showing items 61-85 of 153 (7 Page(s) Totally) << < 1 2 3 4 5 6 7 > >> View [10|25|50] records per page
國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
國立臺灣大學 |
2015 |
Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
國立臺灣大學 |
2015 |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
國立臺灣大學 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu, Chen-Hua; Sheng, Wang-Hui; Sun, Hsin-Yun; Hsieh, Szu-Min; Lo, Yi-Chun; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Liu, Wen-Chun; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 孫幸筠; 劉俊人; 謝思民; 陳培哲; 盛望徽; 洪健清 |
國立臺灣大學 |
2015 |
慢性C型肝炎病毒基因型第一型病患之優化治療
|
劉振驊; Liu, Chen-Hua |
國立臺灣大學 |
2015 |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, Tung-Hung; Shiau, Chung-Wai; Jao, Ping; Liu, Chen-Hua; Liu, Chun-Jen; Tai, Wei-Tien; Jeng, Yung-Ming; Yang, Hung-Chih; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 陳昆鋒; 劉俊人; 陳培哲 |
國立臺灣大學 |
2015 |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
國立臺灣大學 |
2015 |
Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages
|
Liu, Chun-Jen; Chen, Ting-Chih; Chen, Pei-Jer; Wang, Hurng-Yi; Tseng, Tai-Chung; Cheng, Huei-Ru; Liu, Chen-Hua; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 王弘毅 |
國立臺灣大學 |
2015 |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang, Chia-Chi; Liu, Chen-Hua; Lin, Chih-Lin; Wang, Pin-Chao; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
國立臺灣大學 |
2015 |
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
|
Lin, Chih-Lin; Liu, Chen-Hua; Wang, Chia-Chi; Liang, Cheng-Chao; Su, Tung-Hung; Liu, Chun-Jen; Kao, Jia-Horng; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人 |
國立臺灣大學 |
2015 |
The NIACE score helps predict the survival of Asian hepatocellular carcinoma patients
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Adhoute, Xavier; Bourliere, Marc; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
國立臺灣大學 |
2015 |
Benefits of Antiviral Treatment and Predictors of Subsequent Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with or without Sustained Virological Response to Peg-interferon plus Ribavirin Therapy
|
Lee, Mei-Hsuan; Lu, Sheng-Nan; Yu, Ming-Lung; Peng, Cheng-Yuan; Sheen, I-Shyan; Liu, Chen-Hua; Kao, Jia-Horng; Chuang, Wan-Long; Yang, Hwai-I; L'Italien, Gilbert; Yuan, Yong; Chen, Chien-Jen; 劉振驊; 高嘉宏 |
國立交通大學 |
2014-12-08T15:29:51Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng; Hsu, Shih-Jer; Chen, Hung-Chia; Liu, Chen-Hua; Jeng, Jenher; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
國立交通大學 |
2014-12-08T15:12:03Z |
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy
|
Hsu, Ching-Sheng; Hsu, Shih-Jer; Chen, Hung-Chia; Tseng, Tai-Chung; Liu, Chen-Hua; Niu, Wei-Fang; Jeng, Jenher; Liu, Chun-Jen; Lai, Ming-Yang; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn |
臺北醫學大學 |
2014 |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin
|
Chen, Ming-Yao;Liu, Chen-Hua;Chen, Ting-Chih;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng;Liu, Chun-Jen |
國立臺灣大學 |
2014 |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Jeng, Yung-Ming; Cheng, Huei-Ru; Liu, Chen-Hua; Tseng, Tai-Chung; Ling, Thai-Yen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 林泰元; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
國立臺灣大學 |
2014 |
Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
國立臺灣大學 |
2014 |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Chen, Ting-Chih; Tseng, Tai-Chung; Liu, Chen-Hua; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 吳慧琳; 蘇東弘; 劉俊人; 陳培哲 |
國立臺灣大學 |
2014 |
Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
|
Wu, Hui-Lin; Kao, Jia-Horng; Chen, Ting-Chih; Wu, Wen-Hsuan; Liu, Chen-Hua; Su, Tung-Hung; Yang, Hung-Chih; Chen, Ding-Shinn; Chen, Pei-Jer; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
國立臺灣大學 |
2014 |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin
|
Chen, Ming-Yao; Liu, Chen-Hua; Chen, Ting-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Liu, Chun-Jen; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
國立臺灣大學 |
2014 |
A ten-year follow-up of patients with dual chronic hepatitis B and C virus infections: Outcomes and determinants
|
Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
國立臺灣大學 |
2014 |
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Chen, Chi-Ling; Yang, Hung-Chih; Su, Tung-Hung; Wang, Chia-Chi; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
國立臺灣大學 |
2014 |
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfae
|
Liu, Chen-Hua; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
國立臺灣大學 |
2014 |
Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study
|
Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen; 劉振驊; 高嘉宏 |
國立臺灣大學 |
2014 |
Patients with chronic hepatitis C virus infection have an increased risk of non-Hodgkin's lymphoma
|
Su, Tung-Hung; Liu, Chun-Jen; Chen, Chi-Ling; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
Showing items 61-85 of 153 (7 Page(s) Totally) << < 1 2 3 4 5 6 7 > >> View [10|25|50] records per page
|